Press Room
JDRF and Sanofi Announce Expansion of their Joint Research Collaboration to Include Development of Glucose Responsive Insulin Therapies for Treatment of Insulin-Dependent Diabetes
JDRF, the leading global organization funding and advocating for type 1 diabetes (T1D) research, and Sanofi US Services Inc., a subsidiary of Sanofi, ...
Read MoreResearchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months
Researchers from the Massachusetts Institute of Technology (MIT), Boston Children’s Hospital, and several other institutions supported with JDRF funding have shown encapsulated human islet cells transplanted into mice can effectively halt type 1 diabetes (T1D) for up to six months without caus...
Alberta Site Currently Recruiting for ViaCyte Inc. Clinical Trial
The University of Alberta is currently recruiting for its highly anticipated encapsulation trial located in Edmonton, Canada.
Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research
Lilly Canada and JDRF Canada have awarded an additional $120,000 in 2015 towards fellowship grants for promising investigators pursuing type 1 diabetes (T1D) research. Operating through the JDRF Canadian Clinical Trial Network (JDRF CCTN), this program is designed to provide the next generatio...
JDRF in the Globe and Mail, November 30, 2015
JDRF-funded research is making an impact on the lives of over 300,000 Canadians that are affected by T1D. World-renowned diabetes researcher, Dr. James Shapiro, shares his vision for a world without this disease.
Releasing Insulin Like Clockwork
Scientists have shown that disruption of the body’s internal clock system is involved in a range of diseases, from psychiatric to metabolic to cardiovascular.
Collaboration Leads to Invaluable Discoveries
In its early phase, encapsulation research was divided, with experts in different disciplines focused on different aspects of the science. JDRF created the Encapsulation Consortium in 2013, jump-starting the field by encouraging collaboration among its 25+ members and shaping a strategy to guide res...
JDRF in the Globe and Mail, November 12, 2015
JDRF showcases the remarkable people who benefit from JDRF-funded research while striving to accelerate the pace of research in Canada.
New Classification and Staging Approach for Presymptomatic Type 1
JDRF and the American Diabetes Association, in Collaboration with Multiple Diabetes Organizations Publish New Classification and Staging Approach for Presymptomatic Type 1. Diabetes Organizations Endorse Concept that Autoimmune Disease Begins Long Before Symptoms Occur and Progresses through Distinc...
Corporate Canada Mounts Up at the Annual JDRF Ride for Diabetes Research
The stationary bicycles are tuned, greased and ready for corporate Canada to start cycling in support of JDRF at the 2015 JDRF Ride for Diabetes Research (JDRF Ride). This fall, all across Canada various business sectors will trade in their suits for sweats as they go head-to-head in this unique sta...
.png)
